FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224278319> ?p ?o ?g. }

• W4224278319 endingPage "1739" @default.
• W4224278319 startingPage "1732" @default.
• W4224278319 abstract "The Treatment as Prevention for Hepatitis C program started in 2016 in Iceland, offering treatment with direct-acting antivirals to hepatitis C virus (HCV)-infected individuals. Reinfections through injection drug use (IDU) can hamper elimination efforts. We determined reinfection rates of HCV among patients in the program.Clinical data were gathered prospectively. The study cohort consisted of HCV-cured patients with an estimated sustained virologic response between 1 February 2016 and 20 November 2018, with follow-up until 20 November 2019. The observation period and time until reinfection was estimated using a single random point imputation method coupled with Monte Carlo simulation. The reinfection rates were expressed as reinfections per 100 person-years (PY).In total, 640 treatments of 614 patients (417 male; mean age, 44.3 years) resulted in cure, with 52 reinfections subsequently confirmed in 50 patients (37 male). Follow-up was 672.1 PY, with a median time to reinfection of 232 days. History of IDU was reported by 523 patients (84.8%) and recent IDU with 220 treatments (34.4%). Stimulants were the preferred injected drug in 85.5% of patients with a history of IDU. The reinfection rate was 7.7/100 PY. Using multivariate Cox proportional hazards models for interval-censored data, age (hazard ratio, 0.96 [95% confidence interval, .94-.99]) and recent IDU (2.91 [1.48-5.76]) were significantly associated with reinfection risk.The reinfection rate is high in a setting of widespread stimulant use, particularly in young people with recent IDU. Regular follow-up is important among high-risk populations to diagnose reinfections early and reduce transmission.NCT02647879." @default.
• W4224278319 created "2022-04-26" @default.
• W4224278319 creator A5016423843 @default.
• W4224278319 creator A5029171591 @default.
• W4224278319 creator A5041450939 @default.
• W4224278319 creator A5052504129 @default.
• W4224278319 creator A5065274678 @default.
• W4224278319 creator A5074234625 @default.
• W4224278319 creator A5077485209 @default.
• W4224278319 creator A5078223163 @default.
• W4224278319 creator A5083877328 @default.
• W4224278319 creator A5090689190 @default.
• W4224278319 date "2022-04-19" @default.
• W4224278319 modified "2023-10-16" @default.
• W4224278319 title "High Rate of Hepatitis C Virus Reinfection Among Recently Injecting Drug Users: Results From the TraP Hep C Program—A Prospective Nationwide, Population-Based Study" @default.
• W4224278319 cites W1936923812 @default.
• W4224278319 cites W2044811277 @default.
• W4224278319 cites W2059796825 @default.
• W4224278319 cites W2104563699 @default.
• W4224278319 cites W2165019902 @default.
• W4224278319 cites W2177211260 @default.
• W4224278319 cites W2274680380 @default.
• W4224278319 cites W2320330796 @default.
• W4224278319 cites W2395160937 @default.
• W4224278319 cites W2418871445 @default.
• W4224278319 cites W2562778217 @default.
• W4224278319 cites W2578013986 @default.
• W4224278319 cites W2592431769 @default.
• W4224278319 cites W2744072791 @default.
• W4224278319 cites W2776473002 @default.
• W4224278319 cites W2792805866 @default.
• W4224278319 cites W2888122510 @default.
• W4224278319 cites W2913125611 @default.
• W4224278319 cites W2945149169 @default.
• W4224278319 cites W2947953896 @default.
• W4224278319 cites W2950514720 @default.
• W4224278319 cites W2955528799 @default.
• W4224278319 cites W2972668570 @default.
• W4224278319 cites W2978198700 @default.
• W4224278319 cites W2990999638 @default.
• W4224278319 cites W2991934814 @default.
• W4224278319 cites W2995490682 @default.
• W4224278319 cites W3012451215 @default.
• W4224278319 cites W3015339091 @default.
• W4224278319 cites W3111055572 @default.
• W4224278319 cites W3113965032 @default.
• W4224278319 cites W3116589258 @default.
• W4224278319 cites W3120854056 @default.
• W4224278319 cites W3165799749 @default.
• W4224278319 cites W3173571832 @default.
• W4224278319 cites W3194372415 @default.
• W4224278319 cites W3200264553 @default.
• W4224278319 doi "https://doi.org/10.1093/cid/ciac272" @default.
• W4224278319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35438144" @default.
• W4224278319 hasPublicationYear "2022" @default.
• W4224278319 type Work @default.
• W4224278319 citedByCount "6" @default.
• W4224278319 countsByYear W42242783192022 @default.
• W4224278319 countsByYear W42242783192023 @default.
• W4224278319 crossrefType "journal-article" @default.
• W4224278319 hasAuthorship W4224278319A5016423843 @default.
• W4224278319 hasAuthorship W4224278319A5029171591 @default.
• W4224278319 hasAuthorship W4224278319A5041450939 @default.
• W4224278319 hasAuthorship W4224278319A5052504129 @default.
• W4224278319 hasAuthorship W4224278319A5065274678 @default.
• W4224278319 hasAuthorship W4224278319A5074234625 @default.
• W4224278319 hasAuthorship W4224278319A5077485209 @default.
• W4224278319 hasAuthorship W4224278319A5078223163 @default.
• W4224278319 hasAuthorship W4224278319A5083877328 @default.
• W4224278319 hasAuthorship W4224278319A5090689190 @default.
• W4224278319 hasBestOaLocation W42242783191 @default.
• W4224278319 hasConcept C126322002 @default.
• W4224278319 hasConcept C159047783 @default.
• W4224278319 hasConcept C187212893 @default.
• W4224278319 hasConcept C188816634 @default.
• W4224278319 hasConcept C207103383 @default.
• W4224278319 hasConcept C2522874641 @default.
• W4224278319 hasConcept C2776408679 @default.
• W4224278319 hasConcept C2776455275 @default.
• W4224278319 hasConcept C2908647359 @default.
• W4224278319 hasConcept C44249647 @default.
• W4224278319 hasConcept C50382708 @default.
• W4224278319 hasConcept C71924100 @default.
• W4224278319 hasConcept C72563966 @default.
• W4224278319 hasConcept C99454951 @default.
• W4224278319 hasConceptScore W4224278319C126322002 @default.
• W4224278319 hasConceptScore W4224278319C159047783 @default.
• W4224278319 hasConceptScore W4224278319C187212893 @default.
• W4224278319 hasConceptScore W4224278319C188816634 @default.
• W4224278319 hasConceptScore W4224278319C207103383 @default.
• W4224278319 hasConceptScore W4224278319C2522874641 @default.
• W4224278319 hasConceptScore W4224278319C2776408679 @default.
• W4224278319 hasConceptScore W4224278319C2776455275 @default.
• W4224278319 hasConceptScore W4224278319C2908647359 @default.
• W4224278319 hasConceptScore W4224278319C44249647 @default.
• W4224278319 hasConceptScore W4224278319C50382708 @default.
• W4224278319 hasConceptScore W4224278319C71924100 @default.
• W4224278319 hasConceptScore W4224278319C72563966 @default.

• next